MariMed Inc. (OTCMKTS:MRMD) Sees Significant Decline in Short Interest

MariMed Inc. (OTCMKTS:MRMD) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 1,866 shares, a decrease of 88.4% from the June 15th total of 16,030 shares. Based on an average daily volume of 668,174 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

MariMed Price Performance

MariMed stock traded up $0.00 during trading hours on Friday, hitting $0.07. 101,528 shares of the stock were exchanged, compared to its average volume of 327,912. The stock has a market capitalization of $27.15 million, a P/E ratio of -2.27 and a beta of 1.32. MariMed has a 12 month low of $0.06 and a 12 month high of $0.23. The business’s 50-day moving average is $0.07 and its two-hundred day moving average is $0.08. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01). MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.The firm had revenue of $39.48 million during the quarter, compared to analysts’ expectations of $38.75 million. Equities research analysts expect that MariMed will post -0.04 EPS for the current fiscal year.

About MariMed

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.